Every 10-Q that BrightSpring Health Services, Inc. (BTSG) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow BTSG and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full BTSG filings page.
BrightSpring Health Services delivered stronger results for the quarter and six months ended June 30, 2026. For the quarter, total revenues were 3,873,140 and net income was 84,209, up from 3,147,698 and 27,542 a year earlier, with diluted EPS of 0.38 versus 0.13. For the first half of 2026, revenues reached 7,486,861 and net income was 232,819, compared with 6,025,827 and 56,552 in the prior-year period; income from continuing operations rose to 160,887 from 17,757.
From continuing operations, operating income for the first half increased to 251,840 from 99,296, while operating cash flow was 166,859. BrightSpring completed the sale of its Community Living business for cash proceeds of 810,908, generating a pre-tax gain of 101,868 and using 300,000 of proceeds to pay down its term loan before refinancing into a lower-margin Tranche B-6 facility. At June 30, 2026, the company held 550,381 in cash and had total debt, net of issuance costs, of 2,190,760. Tangible Equity Units continued to amortize and 2,526,146 units were converted into common stock, while the company also repurchased 120,000 of common stock during the first half.
BrightSpring Health Services delivered strong first-quarter 2026 results, combining organic growth with a major portfolio reshaping. Revenue rose 25.6% to $3.6 billion, with Pharmacy Solutions up 25.2% to $3.2 billion and Provider Services up 27.9% to $442.4 million.
Income from continuing operations climbed to $74.3 million, while total net income reached $148.6 million, helped by a $103.4 million pre-tax gain on the sale of the Community Living business. Diluted EPS from continuing operations increased to $0.34, and Adjusted EBITDA grew 44.8% to $189.8 million, reflecting better scale and margins in both segments.
The Community Living divestiture generated $810.9 million of cash proceeds and is treated as discontinued operations. Cash and cash equivalents rose to $888.8 million against total debt of about $2.56 billion, resulting in reported leverage of 2.27x. The company also repurchased 1.46 million shares for $60 million alongside a 20 million–share secondary offering by existing holders.
BrightSpring Health Services (BTSG) reported strong Q3 2025 results. Total revenue rose to $3.334 billion from $2.601 billion a year ago, led by Products at $2.967 billion and Services at $367.1 million. Gross profit was $392.0 million and operating income increased to $87.8 million from $29.1 million.
Net income was $55.2 million versus a $9.0 million loss last year; diluted EPS was $0.26 compared with a $0.04 loss. Year-to-date operating cash flow reached $258.6 million. Cash and cash equivalents were $140.3 million, and long-term debt (net of current portion) was $2.465 billion.
The Community Living business is classified as discontinued operations and contributed $17.8 million of income in Q3. The company agreed to sell this business for $835.0 million in cash, with closing expected in the first fiscal quarter of 2026, subject to approvals. In October, selling stockholders completed a 15,000,000-share secondary offering; the company concurrently purchased 1,500,000 of those shares at the underwriter’s purchase price.